Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for ly294002 (compound)
Most Correlated Studies
- Human colorectal cancer cells treated with inhibitors of PI3Kinase - AKT signaling pathway
- Induction of the differentiation processes of PC12 cells with NGF, insulin, U0126, or LY294002
- CD4+ T cells age and culture condition comparisons treated with rapamycin or LY 294002
- Oncogenic PI3K mutations in cancer cells following growth factor deprivation
- Treated keratinocyte HaCaT cell line overexpressing EGFR, RELA (p65), or HRAS-VAL12D
Most Relevant Literature
- Proapoptotic and antimigration properties of osthole in combination with LY294002 against human glio…
- Furanocoumarins as Enhancers of Antitumor Potential of Sorafenib and LY294002 toward Human Glioma Ce…
- Effect of acupuncture preconditioning combined with PI3K blocker LY294002 on airway inflammation in …
- Curative effects and mechanisms of AG1296 and LY294002 co-therapy in Angiostrongylus cantonensis-ind…
- Synergistic effects of LY294002 and ABT199 on the cell cycle in K562, HL60 and KG1a cells.
Most Relevant Clinical Trials
- SF1126 for Patients With Relapsed or Refractory Neuroblastoma
- Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer
- Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)
- Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer
- Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Meta…
